Latest Regulatory Process News

Page 7 of 10
New World Resources has secured a crucial environmental permit for its Antler Copper Project in Arizona, accelerating its path toward construction. This milestone reflects strong state support and positions the company to begin building later in 2025.
Maxwell Dee
Maxwell Dee
25 June 2025
Capricorn Metals has extended its mining contract with MACA Ltd for Karlawinda and named MACA preferred contractor for Mt Gibson, locking in cost certainty and supporting production growth.
Maxwell Dee
Maxwell Dee
24 June 2025
Xstate Resources has appointed joint lead managers for a $2-3 million capital raise aimed at re-compliance with ASX listing rules and trading reinstatement. The company also plans a key acquisition pending shareholder approval.
Maxwell Dee
Maxwell Dee
23 June 2025
Larvotto Resources has secured preliminary regulatory approval to extend mining at its Hillgrove Gold-Antimony Mine through 2026, paving the way for project financing and production ramp-up.
Maxwell Dee
Maxwell Dee
23 June 2025
C29 Metals has secured Category 4 exploration approval for its newly granted eastern tenement in Kazakhstan, advancing its multi-mineral project and gaining strong local community support.
Maxwell Dee
Maxwell Dee
19 June 2025
Diatreme Resources’ Northern Silica Project has been awarded Major Project Status by the Australian Government, marking a pivotal step in advancing critical minerals development in Queensland. This designation streamlines federal approvals and supports the project’s role in the clean energy supply chain.
Maxwell Dee
Maxwell Dee
17 June 2025
ASPI Isotopes Inc. has proposed a scheme to acquire all Renergen shares at a 41.3% premium, aiming to create a global critical materials powerhouse. The deal, subject to shareholder and regulatory approval, will delist Renergen from multiple exchanges.
Maxwell Dee
Maxwell Dee
13 June 2025
Pure Hydrogen Corporation has secured a 15-year Potential Commercial Area approval and extended its ATP 927 permit for the Windorah Gas Project, marking a critical regulatory milestone ahead of its planned spinout.
Maxwell Dee
Maxwell Dee
10 June 2025
Firebrick Pharma has published its pivotal Phase 3 trial results for Nasodine nasal spray, confirming its effectiveness and safety in treating the common cold, especially when used early.
Ada Torres
Ada Torres
10 June 2025
Manuka Resources’ Taranaki VTM Project has advanced through a critical regulatory checkpoint, with no competing applications or appeals standing in its way, moving closer to expert panel determination.
Maxwell Dee
Maxwell Dee
30 May 2025
The Takeovers Panel has imposed interim restrictions on shares issued in Emu NL's recent placement, halting any trading by subscribers pending further review.
Claire Turing
Claire Turing
28 May 2025
Echo IQ’s application for a key US procedural code was rejected but the company plans a swift resubmission, maintaining confidence in its US commercial rollout.
Ada Torres
Ada Torres
21 May 2025